Boston Scientific Corp is > 10% Shareholder of Pulmonx Corp. Currently has a direct ownership of 1.49 Million shares of LUNG, which is worth approximately $9.17 Million. The most recent transaction as insider was on Jul 13, 2021, when has been sold 2,500,000 shares (Common Stock) at a price of $37.45 per share, resulting in proceeds of $93,625,002. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.49M
0% 3M change
0% 12M change
Total Value Held $9.17 Million

BOSTON SCIENTIFIC CORP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 13 2021
SELL
Open market or private sale
$93,625,002 $37.45 p/Share
2,500,000 Reduced 62.69%
1,488,106 Common Stock
Apr 06 2021
SELL
Open market or private sale
$28,339,999 $43.6 p/Share
650,000 Reduced 14.01%
3,988,106 Common Stock
Mar 30 2021
SELL
Open market or private sale
$55,079,999 $40.8 p/Share
1,350,000 Reduced 22.54%
4,638,106 Common Stock
Oct 05 2020
BUY
Conversion of derivative security
-
5,987,965 Added 50.0%
5,988,106 Common Stock
BSC

Boston Scientific Corp

> 10% Shareholder
Marlborough, MA

Track Institutional and Insider Activities on LUNG

Follow Pulmonx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUNG shares.

Notify only if

Insider Trading

Get notified when an Pulmonx Corp insider buys or sells LUNG shares.

Notify only if

News

Receive news related to Pulmonx Corp

Track Activities on LUNG